A leaked letter is fueling a new fight in healthcare over who’s to blame for the high cost of prescription drugs11th February 2019
A leaked letter from one of the most powerful middlemen in healthcare is fueling fresh finger-pointing over who should bear the blame for the high cost of prescription drugs in the US.
In the letter, a middleman in the drug business demanded almost two years of advance notice from pharma companies before they lower the prices of their drugs, according to a note to investors on Friday from Bernstein analyst Ronny Gal. According to Gal, the middleman, OptumRx, also made a second demand of the pharmaceutical companies that could make it difficult for those companies to reduce the list prices of their medications.
Analysts at Bank of America Merrill Lynch said the letter raised worries that OptumRx was pressuring drug companies not to cut their prices.
“This would feed into the narrative that the middlemen in the supply chain are part of the problem for high drug costs,” they said in a research note on Friday.Read full story...